National Biotechnology Initiative Act of 2025
The source supplies the latest action, but no lifecycle stage.
Latest action (9 Apr 2025): Referred to the Committee on Science, Space, and Technology, and in addition to the Committees on Foreign Affairs, Agriculture, Energy and Commerce, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
What this bill does
H.R. 2756, the National Biotechnology Initiative Act of 2025, would direct the President to establish a formal "National Biotechnology Initiative" coordinating federal work on biotechnology across national security, economic competitiveness, research, regulation, workforce, and public education. It creates a new National Biotechnology Coordination Office within the Executive Office of the President, led by a presidentially appointed Director, along with an Interagency Committee drawing senior officials from 13 federal agencies. These bodies would develop a national biotechnology strategy, coordinate research funding, streamline overlapping regulations for biotech products, address biosecurity risks, support workforce training, and build a public website consolidating federal biotechnology information. The bill authorizes $22–35 million per year for fiscal years 2026–2030, administered through the National Science Foundation.
The initiative would primarily affect federal agencies involved in biotechnology policy—including Agriculture, Commerce, Defense, Energy, HHS, and others—by imposing new coordination, reporting, and planning duties. It could also affect biotechnology researchers, companies seeking regulatory clarity, and the public, who would gain access to consolidated information and a system for tracking regulatory pathways for biotech products. The Office is designed to wind down after 20 years, transferring its functions to the Interagency Committee.
The bill was introduced on April 9, 2025, by Rep. Stephanie Bice with Rep. Khanna, and referred to the House Committees on Science, Space, and Technology, Foreign Affairs, Agriculture, Energy and Commerce, and Education and Workforce. It has not yet been voted on and would need committee action and floor votes in both chambers before becoming law.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
9 Apr 2025
Referred to the Committee on Science, Space, and Technology, and in addition to the Committees on Foreign Affairs, Agriculture, Energy and Commerce, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Common questions
- What does H.R. 2756 do?
- H.R. 2756, the National Biotechnology Initiative Act of 2025, would direct the President to establish a formal "National Biotechnology Initiative" coordinating federal work on biotechnology across national security, economic competitiveness, research, regulation, workforce, and public education. It creates a new National Biotechnology Coordination Office within the Executive Office of the President, led by a presidentially appointed Director, along with an Interagency Committee drawing senior officials from 13 federal agencies. These bodies would develop a national biotechnology strategy, coordinate research funding, streamline overlapping regulations for biotech products, address biosecurity risks, support workforce training, and build a public website consolidating federal biotechnology information. The bill authorizes $22–35 million per year for fiscal years 2026–2030, administered through the National Science Foundation. The initiative would primarily affect federal agencies involved in biotechnology policy—including Agriculture, Commerce, Defense, Energy, HHS, and others—by imposing new coordination, reporting, and planning duties. It could also affect biotechnology researchers, companies seeking regulatory clarity, and the public, who would gain access to consolidated information and a system for tracking regulatory pathways for biotech products. The Office is designed to wind down after 20 years, transferring its functions to the Interagency Committee. The bill was introduced on April 9, 2025, by Rep. Stephanie Bice with Rep. Khanna, and referred to the House Committees on Science, Space, and Technology, Foreign Affairs, Agriculture, Energy and Commerce, and Education and Workforce. It has not yet been voted on and would need committee action and floor votes in both chambers before becoming law.
- Has H.R. 2756 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 2756. Check the latest action and official source below.
- Who sponsored H.R. 2756?
- H.R. 2756 was sponsored by Rep. Bice, Stephanie I. [R-OK-5] (R-OK), with 23 cosponsors.
- What's the latest action on H.R. 2756?
- Referred to the Committee on Science, Space, and Technology, and in addition to the Committees on Foreign Affairs, Agriculture, Energy and Commerce, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (9 Apr 2025).
Related bills in Health
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Choices for Increased Mobility Act of 2026
Lower Premiums, Faster Payments Act
Access to Medical Supplies Act
More bills from Rep. Bice, Stephanie I. [R-OK-5]
Celebrating the 50th anniversary of the admission of women to the United States service academies and honoring the pioneering women of the Class of 1980.
No Preference Act
Agriculture and National Security Act of 2026
Duplicative Grant Consolidation Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.